Gemsar Rtu 1.4 g Injection

Description

Injection de Gemsar RTU 1.4 g is a sterile, ready-to-use solution containing Gemcitabine as its active ingredient. Gemcitabine is a nucleoside analog that functions as a chemotherapy agent. It is primarily used in the treatment of various types of cancer, including pancreatic cancer, non-small cell lung cancer, breast cancer, and ovarian cancer. It works by interfering with DNA synthesis, thereby inhibiting the growth and proliferation of cancer cells.

The recommended dosage and administration schedule for Injection de Gemsar RTU 1.4 g should be strictly determined by a qualified healthcare professional based on the specific type and stage of cancer, as well as the patient’s overall health and response to treatment. It is typically administered intravenously. Patients should inform their doctor about any pre-existing medical conditions, allergies, or other medications they are taking before starting treatment. Common side effects may include fatigue, nausea, vomiting, fever, and low blood cell counts. Storage instructions should be followed as per the manufacturer’s guidelines, usually at room temperature and protected from light.